POAI raised $340 million focusing on ATH Token, with the price rising nearly 200%.

robot
Abstract generation in progress

[Coin World] Predictive Oncology Inc. (NASDAQ: POAI) raised approximately $344.4 million through a private sale and launched a digital asset funding strategy focusing on the native Token ATH of the decentralized infrastructure network Aethir. CEO Raymond Vennare described the collaboration as a "landmark event" for expanding core business opportunities, while Aethir's co-founder emphasized POAI's role as an ecosystem operator. Following the announcement, POAI's stock price surged 198.71%, with an Opening Price of $2.1350, before pulling back to $1.34. Meanwhile, the ATH Token rose over 75% within a month, trading at $0.05491, and Aethir's monthly revenue hit a record high of $13 million, with a total duration exceeding 1.16 billion hours.

ATH-13.04%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 3
  • Repost
  • Share
Comment
0/400
No comments
  • Pin
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)